Publication | Open Access
Activity of Contemporary Antifungal Agents, Including the Novel Echinocandin Anidulafungin, Tested against <i>Candida</i> spp., <i>Cryptococcus</i> spp., and <i>Aspergillus</i> spp.: Report from the SENTRY Antimicrobial Surveillance Program (2006 to 2007)
75
Citations
13
References
2009
Year
Fungal DiversityAntifungal AgentAntibioticsContemporary Antifungal AgentsAntifungal AgentsNovel Echinocandin AnidulafunginPathologyVaginitisAmphotericin BReference SusceptibilityCryptococcus Neoformans IsolatesClinical MycologyMicrobiologyInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceFungal Pathogen
Results from the SENTRY international fungal surveillance program for 2006 to 2007 are presented. A total of 1,448 Candida sp., 49 Aspergillus fumigatus, and 33 Cryptococcus neoformans isolates were obtained from infected sterile-site sources in patients on five continents. Reference susceptibility was determined for anidulafungin, caspofungin, 5-flucytosine, fluconazole, itraconazole, posaconazole, voriconazole, and amphotericin B by CLSI methods.
| Year | Citations | |
|---|---|---|
Page 1
Page 1